Fwd: Fighting Breast Cancer Hormone-Therapy Resistance; New Ways to Drain Cancer's Fuel Tank

Sent from my iPad

Begin forwarded message:

From: Kent Castle <kent.d.castle@hotmail.com>
Date: November 25, 2014 at 5:19:32 PM CST
To: Bogan Carole <bcbogan@earthlink.net>, Reason Marilou <loganlou55@yahoo.com>, Patterson James <w8ljz@aol.com>, Astrology Valkyrie <astrogoddess@valkyrieastrology.com>, Bentz Jerry <bentz@sbcglobal.net>, Baird Darren <darren.t.baird@nasa.gov>, Martin Bobby <bobbygmartin1938@gmail.com>
Subject: FW: Fighting Breast Cancer Hormone-Therapy Resistance; New Ways to Drain Cancer's Fuel Tank

 

---

From: reply@mail.dddmag.com
To: KENT.D.CASTLE@HOTMAIL.COM
Subject: Fighting Breast Cancer Hormone-Therapy Resistance; New Ways to Drain Cancer's Fuel Tank
Date: Tue, 25 Nov 2014 10:12:59 -0600

Mali Confirms Eighth Ebola Case; Vascular Solutions Gets Clearance for Tumor Treating Gel-Block

View this email in your browser. NOV 25   IN THIS ISSUE   NEWS     Researchers Identify New Ways to Drain Cancer's 'Fuel Tank'     NEWS     Mali Confirms Eighth Ebola Case     NEWS     Vascular Solutions Gets Clearance for Tumor Treating Gel-Block     NEWS     $1B Alliance Between Menarini, Oxford BioTherapeutics for Enhanced AML Treatment     NEWS     Genetic Test Unlocks Cause of Brisbane Boy's Rare Disease   Pittcon 2015 Pittcon 2015, the world's largest annual conference & expo for laboratory science, March 8-12, 2015, New Orleans, LA. Pittcon offers a premiere exposition, diverse technical program, unique networking & exceptional short courses LEARN MORE     FEATURED STORY Exciting Gains in Fighting Breast Cancer Hormone-Therapy Resistance     Guided by breakthrough research on the Estrogen Receptor 1 (ESR1 ) gene, many researchers and pharmaceutical companies are in hot pursuit of the next big anti-resistance breast cancer drug. Read more...                  Share FULL STORY     10th Annual World Stem Cell Summit The 10th Annual World Stem Cell Summit is the largest interdisciplinary stem cell meeting with organizers from the Mayo Clinic, Kyoto Univ., the Univ. of Texas Health Science Center, BioBridge Global, and many more. You won't want to miss this year's event with NEW tracks focusing on Discovery, Translation and Clinical Trials, Innovation Showcase, Regenerative Services and Capital Markets. LEARN MORE     NEWS Researchers Identify New Ways to Drain Cancer's 'Fuel Tank' Scientists at the University of Manchester have discovered a potential weakness in cancer's ability to return or become resistant to treatment. Read more...                   FULL STORY     NEWS Mali Confirms Eighth Ebola Case Mali has confirmed a new case of Ebola, bringing to eight the number of people who have fallen ill with the deadly disease in the West African country. Read more...                 FULL STORY     NEWS Vascular Solutions Gets Clearance for Tumor Treating Gel-Block Vascular Solutions gets clearance from the FDA for tumor treating gel blocks. Read more...                              FULL STORY     NEWS $1B Alliance Between Menarini, Oxford BioTherapeutics for Enhanced AML Treatment This is the first of five development programs between the two companies to enter the clinic in a $1 billion strategic oncology alliance. Read more...                    FULL STORY     NEWS Genetic Test Unlocks Cause of Brisbane Boy's Rare Disease Queensland researchers have led an international effort to uncover the gene behind a young Brisbane boy's rare developmental condition. Read more...                    FULL STORY   SUBSCRIBE • UNSUBSCRIBE • ABOUT US • ADVERTISE This email was sent by: Drug Discovery & Development 100 Enterprise Drive - Suite 600 - Rockaway, NJ 07866-2129 We respect your right to privacy - click here to view our policy. ©2014 Drug Discovery & Development. All rights reserved.